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A B S T R A C T
Measles virus (MeV) and canine distemper virus (CDV), two members of the Morbillivirus genus, are still causing
important global diseases of humans and animals, respectively. To enter target cells, morbilliviruses rely on an
envelope-anchored machinery, which is composed of two interacting glycoproteins: a tetrameric receptor
binding (H) protein and a trimeric fusion (F) protein. To execute membrane fusion, the F protein initially adopts
a metastable, prefusion state that refolds into a highly stable postfusion conformation as the result of a finely
coordinated activation process mediated by the H protein. Here, we employed cryo-electron microscopy (cryo-
EM) and single particle reconstruction to elucidate the structure of the prefusion state of the CDV F protein
ectodomain (solF) at 4.3 Å resolution. Stabilization of the prefusion solF trimer was achieved by fusing the GCNt
trimerization sequence at the C-terminal protein region, and expressing and purifying the recombinant protein in
the presence of a morbilliviral fusion inhibitor class compound. The three-dimensional cryo-EM map of prefusion
CDV solF in complex with the inhibitor clearly shows density for the ligand at the protein binding site suggesting
common mechanisms of membrane fusion activation and inhibition employed by different morbillivirus mem-
bers.
1. Introduction
Despite the availability of an efficient vaccine, measles virus (MeV)
is still causing outbreaks worldwide that are associated with major
childhood morbidity and mortality in developing countries (Simons
et al., 2012). In most cases, MeV induces an acute disease, although
fatal persistent infections of the central nervous system (CNS) may
occasionally occur (Laksono et al., 2016; Perry and Halsey, 2004;
Ferren et al., 2019). MeV is a pleomorphic enveloped, negative-sense,
single-stranded RNA virus that belongs to the genus Morbillivirus of the
family Paramyxoviridae (de Vries et al., 2015). Morbilliviruses also in-
clude canine distemper virus (CDV), which infects a broad range of
terrestrial and aquatic animals, including endangered species, e.g.,
giant pandas (Feng et al., 2016; Jin et al., 2017). Noteworthy, despite
an overall pathogenesis closely related to MeV, CDV induces much
more frequently severe disorders in the central nervous system (Lempp
et al., 2014).
The morbillivirus cell entry system relies on the concerted action of
two glycoproteins anchored in the viral envelope: the receptor binding
(H) protein and the fusion (F) protein. Initially, the H protein binds to a
surface receptor (SLAM in immune cells or nectin-4 in epithelial cells),
thereby determining the viral tropism. On the other hand, the putative
receptor(s) of MeV and CDV expressed in brain cells remain(s) to be
determined. Upon receptor binding, it is assumed that the H protein
activates the F protein presumably through a series of tightly co-
ordinated conformational changes. In turn, the fusion protein drama-
tically refolds to fuse the envelope of the virus with the host cell plasma
membrane, which allows for the injection of the viral nucleocapsid
(containing the genetic information) into the host cell cytoplasm
(Navaratnarajah et al., 2020; Plattet et al., 2016; Plattet and Plemper,
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2013).
Both, MeV and CDV F protomers are first synthesized as long in-
active precursors, which must be cleaved by furin proteases residing
within the Golgi apparatus to achieve trimeric fusion-competent, dis-
ulfide-linked, F1 and F2 subunits. Such primed trimeric F complexes are
characterize by a high energy-containing state (i.e., metastable), which
is commonly referred to as the prefusion conformation. F protomers
contain well-characterized functional domains: an N-terminal signal
peptide, N- and C-terminal heptad repeat (HRA and HRB) domains, a
transmembrane region and a C-terminal cytosolic tail. Importantly,
upon proteolytic cleavage, a new N-terminal hydrophobic region is
generated, also known as the fusion peptide (FP) (Plattet et al., 2016).
To fuse the viral envelope with the host cell plasma membrane, it is
assumed that activated prefusion F complexes first refold into an in-
termediate state (referred to as the pre-hairpin intermediate (PHI)
structure), which propels the FP towards the target membrane. Subse-
quently, PHI complexes undergo further structural rearrangements to
ultimately achieve a highly-stable and low energy state (referred to as
the postfusion conformation), which is associated with membrane
merging. The postfusion conformation is characterized by a typical six-
helix bundle (6HB) core domain that results from the assembly of three
HRA and HRB domains (Brindley et al., 2014; Plattet et al., 2016).
Noteworthy, 6HB structures are reminiscent to all class I viral glyco-
proteins (e.g., influenza HA, Ebola GP or human immunodeficiency
virus ENV GP41 proteins) in their postfusion conformation (Harrison,
2015; Kielian, 2014).
Recently, the crystal structure of the MeV F ectodomain in the
prefusion state (MeV solF) was determined (Hashiguchi et al., 2018).
The structure was closely related to previously elucidated prefusion
forms of fusion glycoproteins of other paramyxoviruses and pneumo-
viruses. Such structures displayed “tree-like” shapes featuring a stalk
domain supporting a large globular, or more oval, head region
(Hashiguchi et al., 2018; McLellan et al., 2013; Welch et al., 2012;
Wong et al., 2015; Xu et al., 2015; Yin et al., 2005). To achieve proper
expression yield of MeV solF, Hashiguchi and colleagues employed a
“locked-stalk” approach that is based on the introduction of supple-
mentary stabilizing disulfide bridges within the stalk region
(Hashiguchi et al., 2018); a strategy recently proven to be effective in
case of stabilizing the prefusion state of the respiratory syncytial virus F
protein (Stewart-Jones et al., 2015). Two structurally-independent in-
hibitors of the fusion process (AS-48 and FIP) were also co-crystallized
with MeV solF prefusion constructs. Both inhibitors were demonstrated
to dock on identical pocket microdomains, which localized at the
structural transition between the head and the stalk domain with a
stoichiometry of three ligands per trimeric complex (Hashiguchi et al.,
2018).
Here, to stabilize soluble CDV F ectodomain (solF) in the prefusion
state, we fused the trimeric GCNt peptide to the stalk domain, and
expressed and purified solF in mammalian cells in the presence of 3G
(Sun et al., 2006; Singethan et al., 2010), a derivative of AS-48
(Plemper et al., 2005). We recently reported that this strategy effi-
ciently stabilizes prefusion solF (Kalbermatter et al., 2019). By em-
ploying cryo-electron microscopy (cryo-EM) and single particle re-
construction, we successfully determine the three-dimensional (3D)
structure of prefusion CDV solF at 4.3 Å resolution.
2. Materials and methods
2.1. Expression and purification of CDV solF in the presence of 3G
The CDV solF construct (Ader et al., 2013) was codon-optimized and
sent to a protein-expression core facility for protein production (LBTC,
EPFL, Switzerland). Briefly, ~2·109 of HEK293 cells grown in suspen-
sion were transfected with 3 mg of expression plasmid. Cells were
grown in the presence of 75 µM 3G fusion inhibitor, which we syn-
thetized as described previously (Sun et al., 2006). The supernatant
(1 l) was harvested after seven days of expression at 37 °C. Then, 2 ml of
hemagglutinin (HA) epitope-tag antibody-agarose conjugate (50%
slurry, Pierce™) was filled into an Econo-Column® Chromatography
Column, 1.0 × 5 cm (BioRad). The column was packed and first rinsed
with buffer A (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 100 µM EDTA,
and 75 µM of the fusion inhibitor 3G (Sun et al., 2006; Singethan et al.,
2010) using a peristaltic pump (BioRad) at a flow rate of 0.7 ml/min.
The supernatant was added to the column, which was then rinsed with
20 ml of buffer A (same flow rates). Finally, three subsequent elutions
were performed by adding 1 ml of buffer B (HA peptide (Pierce™) re-
constituted to 1 mg/ml in buffer A) to the resin. All purification steps
were performed at 4 °C.
2.2. Cryo-EM grid preparation, data acquisition and movie processing
Purified CDV solF was diluted to 230 µg/ml with 20 mM Tris-HCl
pH 7.5, 100 mM NaCl, 100 µM EDTA and 75 µM of the fusion inhibitor
3G. 2.5 µl were applied to glow-discharged (10 mA, 120 s, 0.25 mbar)
holey carbon grids (Cu R2/1, 200-mesh, Quantifoil), blotted for 4.5 s
and then plunge-frozen in liquid ethane using a Vitrobot Mark IV ap-
paratus (Thermo Fisher Scientific) operated at approximately 100%
humidity and cooled to 4 °C. The grids were stored in liquid nitrogen
until further use.
Cryo-EM images were recorded using SerialEM (Mastronarde, 2005)
at the C-CINA (Center for Cellular Imaging and NanoAnalytics) in Basel,
Switzerland on a FEI Polara microscope (Thermo Fisher Scientific)
operated at 300 kV and equipped with a K2 Summit direct electron
detector (Gatan). Movies of 48 frames were recorded in super-resolu-
tion counting mode at a magnification of 35,000× (pixel size 0.5105 Å)
with a dose of 1.516 e-/Å2/frame, resulting in a total accumulated dose
on the specimen level of approximately 72.8 e-/Å2 per exposure.
The Focus program (Biyani et al., 2017) was used to process the
acquired movies during the imaging session with the following steps:
Gain reference application by IMOD (Kremer et al., 1996), twofold
binning by FREALIGN (Grigorieff, 2007), motion-correction and dose-
weighting by MotionCor2 (Zheng et al., 2017), and contrast transfer
function (CTF) estimation by CTFFIND4 (Rohou and Grigorieff, 2015).
Images displaying high drift, ice-contaminations or a resolution worse
than 8 Å according to the CTF estimation were excluded from further
analysis, resulting in a total of 1,604 aligned movies (see Fig. 1 for a
representative electron micrograph).
Fig. 1. Cryo-EM of purified CDV solF protein. A representative electron mi-
crograph (defocus −2.0 µm) of vitrified CDV solF particles (top) and 2D classes
in different orientations (bottom) are displayed. The scale bar represents 100 nm
and the frame size of the 2D classes in the gallery is 16 nm.
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2.3. Image processing, model building and refinement
All image processing steps were performed with RELION-3 (Zivanov
et al., 2018). An initial particle set was picked without templates using
the auto-picking procedure based on a Laplacian-of-Gaussian filter and
then 2D classified. The best 2D classes were used for a template based
auto-picking resulting in a dataset of 491,315 particles, which was
cleaned through three rounds of 2D classification. The remaining
182,589 particles were used to generate a rotationally symmetric (C3)
starting 3D map with the stochastic gradient descent algorithm of the
RELION-3 software for 3D processing. After two rounds of 3D classifi-
cation (with eight and three 3D classes), 115,248 particles were used
for 3D refinement and resulted in a 4.7 Å map. With the in RELION-3
newly implemented Bayesian polishing (Zivanov et al., 2019), the map
resolution could be improved to 4.4 Å. 3D refinement, modulation
transfer function (MTF) correction and map sharpening were performed
with RELION-3, and resulted in a final map with an overall resolution of
4.3 Å according to the Fourier shell correlation (FSC) curve between
two independently refined half-maps at FSC = 0.143 (Fig. 2A). Local
resolution estimation was performed with the RELION-3 wrapper for
the ResMap algorithm (Kucukelbir et al., 2014).
Homology model of CDV solF was generated by SWISS-MODEL
(Waterhouse et al., 2018) based on the biological unit of the MeV fusion
protein ectodomain (MeV solF) X-ray structure (PDB-ID: 5YZC). The
PHENIX Dock in map tool (Liebschner et al., 2019) was used for initial
rigid-body fitting and further refinement was performed with PHENIX
real-space refinement (Afonine et al., 2018). To improve the fit and
geometry of the model, several iterations of manual adjustment in Coot
(Emsley et al., 2010) and structure validation with the MolProbity web
service (Chen et al., 2010) were carried out. Data collection, processing
and refinement statistics can be found in Table 1. The original electron
micrographs, the cryo-EM map and the protein coordinates were de-
posited in the Electron Microscopy Public Image Archive (EMPIAR-
10366), in the Electron Microscopy Data Bank (EMD-10649) and in the
Protein Data Bank (PDB-ID: 6XYE), respectively. All volume and
structural representations were prepared using Chimera v1.12
(Pettersen et al., 2004) or PyMol v2.3 (The PyMol Molecular Graphics
System, Schrödinger).
3. Results and discussion
3.1. CDV F ectodomain expression and purification
For cryo-EM single particle reconstruction, the previously reported
CDV solF construct (Ader et al., 2013) was expressed in HEK293 cells
and purified by affinity chromatography (for details, see Materials and
methods). In this construct, the transmembrane domain and the cyto-
plasmatic C-terminal part were replaced by a trimeric GCN3 motif
(GCNt), which should stabilize the prefusion state. However, we have
recently shown by negative-stain electron microscopy, that despite this
prefusion-stabilizing GCNt trimerization motif, a considerable amount
of solF spontaneously refolded into postfusion state (Kalbermatter et al.,
2019). Therefore, to ensure a sample of predominantly prefusion state
solF for cryo-EM single particle reconstruction, a high concentration
(75 µM) of the fusion inhibitor 3G (Sun et al., 2006; Singethan et al.,
2010) was present during protein expression and purification.
3.2. Structure determination and overall structure of CDV solF
Cryo-EM data of purified solF were acquired on a 300 kV FEI Polara
Fig. 2. Cryo-EM data analysis of CDV solF protein. (A) The plot shows the Fourier shell correlation (FSC) curve of the final calculated density map. The reported
resolution is based on the FSC = 0.143 criterion. (B) Angular distribution plots of particles included in the final 3D reconstruction viewed from two different angles.
The height of the cylinder is proportional to the number of particles for the corresponding view. (C) The final 3D reconstruction of CDV solF is shown in three
different views (top, side and bottom) and colored according to the local resolutions estimated by ResMap (Kucukelbir et al., 2014).
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electron microscope equipped with a direct electron detector. Electron
micrographs displayed a homogenous distribution of triangular shaped
particles (Fig. 1) corresponding to the prefusion state of CDV solF, be-
cause in the postfusion state CDV solF adopts a less compact and more
elongated tadpole-like shape (Kalbermatter et al., 2019). Also after
reference-free auto-picking and initial 2D-classification, no postfusion-
like 2D classes appeared. This shows that the fusion inhibitor 3G effi-
ciently stabilizes the prefusion state of CDV solF. The initially calcu-
lated 2D classes were used for a template-based auto-picking and the
resulting particles were cleaned through several rounds of 2D classifi-
cation before an initial 3D map was calculated (Materials and methods).
After further removal of bad particles by rounds of 3D classification and
improving the 3D map by particle polishing, 3D refinement and map
sharpening, a final 3D map was calculated from 115,248 particles.
Despite the preferred orientations of these particles (Fig. 2B), a 3D re-
construction with an overall resolution of 4.3 Å was obtained (Fig. 2A;
Materials and methods). The local resolution analysis of the map
showed that in the core of the map the resolution was better (i.e., <
4.3 Å) than at the periphery (Fig. 2C).
Since the sequence identity between the ectodomains of CDV F and
MeV F is high (~72%), a homology model based on the X-ray structure
of the MeV solF (Hashiguchi et al., 2018) was generated and fitted into
the cryo-EM density map. The geometry of the structure and the fit into
the map was improved manually and through several real space re-
finement runs. The final CDV solF model is shown in Fig. 3A and B,
which displays the known “tree”-like fold of the prefusion state of
morbillivirus F proteins (Plattet et al., 2016): The HRB domain of the
three chains form a helix bundle, i.e., a short stalk, which supports a
large globular head domain consisting of the three subdomains DI, DII
and DIII (Fig. 3C). The DI and DII subdomains of the three monomers
form the base of the head and are composed of mainly β-sheets, i.e., DI
two short α-helices and three antiparallel β-sheets with different
amounts of strands (i.e., two, three and four strands) and DII two three-
stranded antiparallel β-sheets. The DIII subdomains consist of α-helix
and β-sheet elements, and are located at the top of the head structure.
One DIII subdomain consists of two long α-helices, five shorter α-he-
lices with less than ten residues per helix and a five-stranded twisted
antiparallel β-sheet. The fusion peptide (FP), which is built from mostly
hydrophobic residues and is important for membrane fusion (Plattet
et al., 2016), is buried between a DII and DIII subdomain of two dif-
ferent monomers.
The CDV F protein has three N-linked glycosylation sites. This is
consistent with previous biochemical studies, which demonstrated
those sites to be glycosylated (von Messling and Cattaneo, 2003). One
N-linked glycosylation site (N173) has been shown to be important for
proper protein folding, whereas the other two (N141 and N179) play a
supporting role in the fusion function (von Messling and Cattaneo,
2003). In the CDV solF structure, N173 and N179 are located at the top
of the head domain in the DIII subdomain, and N141 is located at the
bottom close to the HRB region in the DI subdomain. Interestingly, for
all three N-linked glycosylation sites, additional densities were found in
the cryo-EM map (arrowheads in the side view of Fig. 3A), which would
correspond to glycans. This indicates that the recombinantly expressed
CDV solF protein is glycosylated.
3.3. Inhibitor binding pocket location and description
In the MeV solF crystal structure it has been shown that AS-48 binds
to a hydrophobic pocket located in the region connecting the head and
the stalk of the MeV F trimer with a stoichiometry of three inhibitors
per MeV F trimer (Hashiguchi et al., 2018). Since 3G is a derivative of
AS-48 (Plemper et al., 2005) and the compounds exhibit IC50s for
membrane fusion in the single digit micromolar range against CDV and
MeV (Singethan et al., 2010), it is expected that both inhibitors bind to
the same site. Indeed, the cryo-EM map of CDV solF showed additional
densities (circles in bottom view of Fig. 3A and Supplementary Fig. 1)
in the region of the AS-48 binding site identified in the MeV solF crystal
structure (Hashiguchi et al., 2018).
All three protomers of the CDV solF trimer are involved in one single
putative inhibitor binding pocket. Despite the similar fold and the high
sequence identity (~72%) between the MeV F and CDV F ectodomains,
two amino acids involved in inhibitor binding are different between the
two morbilliviruses. At position 467 in MeV F, CDV F has also a hy-
drophobic amino acid, i.e., a leucine (L579) instead of an isoleucine
(Fig. 4). The more interesting difference is the alanine at position 563 in
CDV F instead of a proline (P451) in MeV, because proline has an ex-
ceptional conformational rigidity compared to alanine (black amino
acids displayed as ball-and-stick in Fig. 4). Indeed, the backbone car-
bonyl oxygen of A563 in CDV solF is slightly turned away from the
center of the putative inhibitor binding pocket compared to the back-
bone carbonyl oxygen of P451 in MeV solF (Fig. 4). This backbone
carbonyl oxygen is in hydrogen bonding distance to the amide nitrogen
of AS-48, which suggest an important role of P451 in the inhibitor
binding mechanism. Despite the hydrophobic nature of the fusion in-
hibitor binding pocket, AS-48 in MeV solF can form three hydrogen
bonds with the surrounding amino acids: (i) the above mentioned hy-
drogen bond between the backbone carbonyl oxygen of P451 and the
amide nitrogen of AS-48; (ii) the protein backbone nitrogen of S453 and
the carbonyl oxygen of AS-48, and (iii) the side chain hydroxyl group of
T369 and the nitro-group of AS-48 (Fig. 4B).
The additional densities observed in the CDV solF 3D map (circles in
bottom view of Fig. 3A and Supplementary Fig. 1) at sites corre-
sponding to the AS-48 inhibitor binding pockets in the MeV solF
structure (Hashiguchi et al., 2018) together with our previous ob-
servation that 3G stabilizes the prefusion state in our recombinant
Table 1
Data collection and model validation statistics.
Data Collection
Microscope FEI Polara
Voltage (kV) 300
Camera Gatan K2 Summit
Defocus range (µm) 0.9 to 3.4
No. of movies 1,604
Frames per movie 48
Total dose per movie (e−/Å2) 72.8
Pixel size (Å) 0.5105
Reconstruction
Software RELION-3
Symmetry C3
Particles refined 115,248
Map Resolution (Å)* 4.3
Map sharpening B-factor (Å2) −206
Refinement and Validation
Software Phenix 1.16–3546
Model composition
Non-hydrogen atoms 9,834
Protein residues 1,293
MolProbity Score 1.88
All-atom clashscore 10.97
Rotamers
Favored (%) 98.1
Outliers (%) 0
Ramachandran
Favored (%) 95.3
Outliers (%) 0
RMS deviations
Bond length (Å) 1.37
Bond angles (°) 0.01
Mean B-factors
Protein (Å2) 87.7
CaBLAM outliers (%) 0.9
Cα Geometry outliers (%) 0
Cβ Deviations > 0.25 Å (%) 0
*Resolution was determined by FSC between two half-maps using 0.143
as a cutoff.
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protein (Kalbermatter et al., 2019) led us to the conclusion that 3G
binds to CDV solF also with a stoichiometry of three molecules per
trimer. However, because of the moderate overall resolution of the
calculated cryo-EM map, no reliable determination of the mode of
binding of the fusion inhibitor could be drawn. We hence decided to
exclude 3G molecules from the CDV solF model.
In summary, we have provided the cryo-EM structure of CDV solF
prefusion state at 4.3 Å resolution. The overall solF architecture is si-
milar to related paramyxovirus fusion proteins in their prefusion con-
formations such as MeV. Comparison of the fusion inhibitor binding
sites of solF from CDV and MeV revealed minor differences, which
could allow for the design of improved versions of inhibitors common
Fig. 3. Cryo-EM map and model of prefusion CDV solF trimers. (A) Three different views of the prefusion CDV solF protein model and the cryo-EM map are shown.
The three protomers of the model are differently colored (yellow, red and green) and displayed as a ribbon model. The cryo-EM map is visualized as a transparent
volume. In the side view, the stalk region is indicated by an asterisk and the densities of the three N-linked glycosylation sites (N141, N173 and N179) are marked
with arrowheads. In the bottom view, the locations of the three binding sites with the densities for the inhibitor 3G are highlighted with black circles. For more
clarity, the views were slabbed. (B) The full CDV solF model is shown and viewed from the side. The trimeric nature of CDV F is indicated by three different colors for
the three protomers (yellow, red and green). (C) On the left side, all the three protomers of CDV F are shown and colored according to the different structural domains
as defined for the prefusion PIV5 F structure (Yin et al., 2006). On the right side, only one protomer is shown with the same coloring: HRB, cyan; Fusion Peptide (FP),
black; DI, magenta; DII, orange; DIII, blue.
Fig. 4. Comparison of the inhibitor binding pocket
of CDV solF and MeV solF. Bottom views of the
prefusion CDV solF (A) or MeV solF (PDB entry
5YZC; (Hashiguchi et al., 2018)) structures (B) are
displayed (top). In the models, the three protomers
are differently colored: (A) yellow, red and green;
(B) cyan, orange and magenta. A magnified view of
the CDV solF binding pocket (A) and the same view
of the MeV solF binding pocket with bound AS-48
(B) are shown (bottom). The side chains of the amino
acids within a distance of 4 Å from the AS-48 mo-
lecule in MeV solF and the corresponding amino
acids in CDV solF are displayed. The hydrophobic
amino acid residues are displayed as sticks and the
amino acid residues in hydrogen bonding distance to
AS-48 in MeV solF (B) (and the corresponding amino
acids in CDV solF (A)) are displayed as ball-and-
sticks. The hydrogen bonds to AS-48 are indicated
with broken lines and the distances are given in Å.
Amino acids that are different between CDV and
MeV are colored in black. The protomers are colored
as in the models in the top panel.
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to both morbillivirus fusion machineries. Importantly, the CDV solF
prefusion structure now offers new opportunities to further engineer
the protein and achieve high-quality immunogens for next-generation
vaccine design and development of desired antiviral drugs.
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